Stereotaxis, Inc. (STXS) Stock Grade

About Stereotaxis, Inc.'s fundamentals

Stereotaxis is a small-cap healthcare company with a $123.4M market capitalization that manufactures medical instruments and supplies. The company demonstrated strong revenue growth of 20.3% year-over-year, indicating expanding sales in its business operations. However, the company is currently unprofitable, with a net margin of -66.9%, and reported a net loss in its latest annual statement, meaning expenses significantly exceed revenues. The company does not pay a dividend and lacks sufficient earnings to calculate standard valuation metrics like P/E ratio and return on equity.